Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CircNFIB inhibits tumor growth and metastasis through suppressing MEK1/ERK signaling in intrahepatic cholangiocarcinoma
Jinpeng Du, Tian Lan, Haotian Liao, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

CircPCNXL2 promotes tumor growth and metastasis by interacting with STRAP to regulate ERK signaling in intrahepatic cholangiocarcinoma
Shuochen Liu, Yirui Wang, Tianlin Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Mechanisms and therapeutic implications of gene expression regulation by circRNA-protein interactions in cancer
Nan Zhang, Xinjia Wang, Yu Li, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Establishment and characterization of three gemcitabine-resistant human intrahepatic cholangiocarcinoma cell lines
Jian‐Dong Li, Yanxin Hu, Jiayao Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
CircZNF215 promotes tumor growth and metastasis through inactivation of the PTEN/AKT pathway in intrahepatic cholangiocarcinoma
Wenwei Liao, Jinpeng Du, Lian Li, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 16
N6-methyladenosine-modified circSLCO1B3 promotes intrahepatic cholangiocarcinoma progression via regulating HOXC8 and PD-L1
Jing Li, Xiaohong Xu, Kaihao Xu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 6
Circular RNAs in cholangiocarcinoma
Wenwei Liao, Qingbo Feng, Huixian Liu, et al.
Cancer Letters (2022) Vol. 553, pp. 215980-215980
Closed Access | Times Cited: 23
CircUGP2 Suppresses Intrahepatic Cholangiocarcinoma Progression via p53 Signaling Through Interacting With PURB to Regulate ADGRB1 Transcription and Sponging miR‐3191‐5p
Rui Xiang Chen, Shuo Chen Liu, Xue Chun Kan, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 4
Engineering circular RNA medicines
Xiaofei Cao, Zhengyi Cai, Jinyang Zhang, et al.
Nature Reviews Bioengineering (2024)
Closed Access | Times Cited: 4
Exosomal circular RNAs in tumor microenvironment: An emphasis on signaling pathways and clinical opportunities
Junshu Li, Wencheng Zhou, Huiling Wang, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 4
Arginase 1 promotes hepatic lipogenesis by regulating ERK2/PPARγ signaling in a non-canonical manner
Yujun Shi, Mingyang Shao, Xiaoyue Cao, et al.
Research Square (Research Square) (2025)
Closed Access
Hypoxia-induced circPLOD2a/b promotes the aggressiveness of glioblastoma by suppressing XIRP1 through binding to HuR
An-Lu Yu, Yiqi Wang, Chao Duan, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
The role of tumor-derived exosomal LncRNA in tumor metastasis
Zhongren Yu, Jiali Fu, Vanya Mantareva, et al.
Cancer Gene Therapy (2025)
Closed Access
Circular RNAs modulate cancer drug resistance: advances and challenges
Jinghan Hua, Zhe Wang, Xiangfei Cheng, et al.
Cancer Drug Resistance (2025)
Open Access
Immunotherapy of cholangiocarcinoma: Therapeutic strategies and predictive biomarkers
Ruyin Chen, Dandan Zheng, Qiong Li, et al.
Cancer Letters (2022) Vol. 546, pp. 215853-215853
Closed Access | Times Cited: 21
CircRNAs regulate the crosstalk between inflammation and tumorigenesis: The bilateral association and molecular mechanisms
Javeria Qadir, Shuo‐Yang Wen, Hui Yuan, et al.
Molecular Therapy (2022) Vol. 31, Iss. 6, pp. 1514-1532
Open Access | Times Cited: 19
A Novel Trojan Horse Nanotherapy Strategy Targeting the cPKM‐STMN1/TGFB1 Axis for Effective Treatment of Intrahepatic Cholangiocarcinoma
Zhi‐Wen Chen, Feng‐Ping Kang, Chengke Xie, et al.
Advanced Science (2023) Vol. 10, Iss. 32
Open Access | Times Cited: 12
circPSD3 is a promising inhibitor of uPA system to inhibit vascular invasion and metastasis in hepatocellular carcinoma
Liangliang Xu, Peng Wang, Li Li, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Circ-RAPGEF5 promotes intrahepatic cholangiocarcinoma progression by stabilizing SAE1 to facilitate SUMOylation
Junhao Zheng, Yali Wang, Liye Tao, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 8
MDIG-mediated H3K9me3 demethylation upregulates Myc by activating OTX2 and facilitates liver regeneration
Jinpeng Du, Wenwei Liao, Haichuan Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 8
Non-Coding RNA in Cholangiocarcinoma: An Update
Jiehan Li, Haolin Bao, Ziyue Huang, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 8
Open Access | Times Cited: 7
Inactivation of the TGF-β1/ALK5 axis enhances club cell function and alleviates lung tissue damage to ameliorate COPD progression through the MEK/ERK signaling pathway
Jing Tian, Hui Ouyang, Jie Wu, et al.
General Physiology and Biophysics (2024) Vol. 43, Iss. 01, pp. 37-48
Open Access | Times Cited: 2
Circular RNAs in Breast Cancer: An Update
Haolin Bao, Jiehan Li, Qihang Zhao, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 158-158
Open Access | Times Cited: 2
Biological functions of circRNA in regulating the hallmarks of gastrointestinal cancer (Review)
Meng-jun Qiu, Youxiang Chen, Chunyan Zeng
International Journal of Oncology (2024) Vol. 64, Iss. 5
Open Access | Times Cited: 2
Epigenetic Modifiers in Cancer Metastasis
Die Hu, Tianci Zhao, Chenxing Xu, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 916-916
Open Access | Times Cited: 2
Circular RNA SMARCA5 inhibits cholangiocarcinoma via microRNA-95-3p/tumor necrosis factor receptor associated factor 3 axis
Guangxin Wang, Xia Gao, Zhi‐Jun Sun, et al.
Anti-Cancer Drugs (2023)
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top